Alterome
Oncology Therapeutics

Alterome news and milestones

Alterome: 24 headlines on record, 5 headlines in the last 90 days. Its story counts 2 milestones.

Data updated Nov 17, 2026 · Back to the company report
24Headlines
5In 90 days
2Milestones

Headlines

Sep 112026
News · Pulse 2.0
Alterome Therapeutics has appointed Johanna Mylet, CPA, Chief Financial Officer as the clinical-stage precision oncology company advances its pipeline of KRAS-targeting cancer th…
Sep 82026
Blog
Former Poseida Therapeutics CFO joins Alterome Therapeutics as the company prepares to accelerate development of KRAS-targeting medicines The post Alterome Therapeutics Appoints…
Mar 102026
Blog
The post Alterome Therapeutics to Participate in Upcoming Investor Conferences appeared first on Alterome.
Feb 22026
Blog
Veteran medical oncologist with a proven track record of advancing cancer therapies from early trials through regulatory approval to lead ongoing clinical development of ALTA2618…
Feb 22026
News · PRNewswire
PRN_FinancialWrapper
Sep 22, 20252025
Award
The post Alterome Therapeutics, Inc. named one of Fierce Biotech's 2025 Fierce 15 appeared first on Alterome.
Apr 10, 20252025
Blog
The post Alterome Therapeutics Announces New Chief Executive Officer and Chair of the Board of Directors appeared first on Alterome.
Mar 10, 20252025
Blog
The post Alterome Doses First Patient in Phase 1 Study of ALTA3263, a Novel Pan-KRAS Dual ON/OFF Inhibitor, in Advanced Solid Tumors appeared first on Alterome.
Jan 15, 20252025
Blog
The post Imagenomix Corp. Partners with Alterome Therapeutics Inc. to Enhance Precision Oncology Clinical Trials with AI appeared first on Alterome.
Oct 30, 20242024
Blog
The post Alterome Therapeutics Announces First Patient Dosed in Phase 1 Study of ALTA2618 in AKT1 E17K-mutant solid tumors (AKTive-001) appeared first on Alterome.
Oct 25, 20242024
Blog
The post Alterome Therapeutics to Present Preclinical Data for its KRAS Selective Inhibitor ALTA3263 at the 2024 ENA Symposium appeared first on Alterome.
Oct 17, 20242024
Award
The post Eric Murphy, Ph.D., Co-Founder and CEO of Alterome, Named to Goldman Sachs Top 100 Most Exceptional Entrepreneurs at 2024 Builders and Innovators Summit appeared first o…
Apr 8, 20242024
News · Pulse 2.0
Alterome Therapeutics, a biopharmaceutical company pioneering the development of small-molecule targeted therapies for cancer treatment, announced the closing of a $132 million S…
Apr 3, 20242024
News · YahooFinance
Biotechnology firm Alterome Therapeutics said on Wednesday it has raised $132 million in a series B financing round, which was led by Goldman Sachs Alternatives. The series B fin…
Apr 3, 20242024
Press release · Nasdaq
Alterome Therapeutics, Inc., a biopharmaceutical company pioneering the development of next generation, small molecule targeted therapies for the treatment of cancer, today annou…
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Alterome, News. Alion, Nov 17, 2026. https://alion.io/company/world-16/news

.json · .md · CC BY-SA 4.0